MAR 12, 2015 1:10 PM PDT

Scientists Sequence Genome of Classical Hodgkin Lymphoma

WRITTEN BY: Ilene Schneider
A team of researchers has sequenced the genome of classical Hodgkin lymphoma, illuminating exactly which proteins are altered in individual patients. The findings could pave the way to delivering personalized treatments and more effective options, since current treatments can be toxic and don't work for nearly 20 percent of patients diagnosed with the disease.

In the study, published Dec. 8 and as a plenary paper in the Feb. 12 issue of Blood, researchers sequenced the genomes of 10 different patients, creating a catalog of mutations in the harmful Reed-Sternberg cells that characterize classical Hodgkin lymphoma (cHL). Armed with this information, scientists can develop drugs that target these specific alterations to compensate for what has gone awry.

"Now we have a better idea of what mutations there are, and going forward therapies can be adapted to specific patient populations according to their genomic composition," said senior author Dr. Ethel Cesarman, professor of pathology and laboratory medicine at Weill Cornell Medical College.

Although scientists have sequenced the genomes of many other diseases, the cHL genome has remained elusive due to the difficulty of isolating Reed-Sternberg cells, which usually comprise less than 1 percent of a total cHL tumor. The team employed a technique that separates larger cells and looks at the proteins on their surface, called fluorescence-activated cell sorting, to isolate the Reed-Sternberg cells and sequence the cancer genome, said senior author Dr. Mikhail Roshal, a pathologist at Memorial Sloan Kettering Cancer Center.

Once the researchers could see the genes of the cancerous cells, they examined the data for trends. About two-thirds of patients had mutations in the protein Beta-2-microglobulin, which make the Reed-Sternberg cells hide from the immune system. Patients with this mutation actually have a fairly positive prognosis, with nearly an 80 percent likelihood of being cured. Though their outcomes may originate in their typically younger ages - the median age of patients with this mutation is 30, compared with 47 for those without it - and tumor subtype, which is less aggressive than other forms of Hodgkin, understanding this common mutation allows scientists to continue improving existing medications, perhaps by reducing the dosage, Cesarman said.

Working with graduate student and first author Jonathan Reichel, Cesarman and Roshal also discovered other mutations in the cells that already have been cataloged, studied or have a corresponding treatment in other cancers. In these cases, doctors can sequence a cHL patient's tumor (which is already common practice for other cancers and now feasible for cHL), identify their altered gene, and provide an effective corresponding treatment.

"Being able to sort and purify these cells was a breakthrough," Cesarman said. "Knowing the genomics can eventually help to personalize treatment for these patients."

Source: Cornell University
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
MAY 15, 2020
Genetics & Genomics
It Only Takes One Gene For Virgin Birth in Honey Bees
MAY 15, 2020
It Only Takes One Gene For Virgin Birth in Honey Bees
Cape honey bees are found in South Africa, and while they look similar, they are very different from other subspecies of ...
JUN 07, 2020
Genetics & Genomics
An Imaging Tool That Could Speed the Diagnosis of Rare Diseases
JUN 07, 2020
An Imaging Tool That Could Speed the Diagnosis of Rare Diseases
When children have a rare genetic disease and do not have access to whole-genome sequencing and the analysis it requires ...
JUN 10, 2020
Genetics & Genomics
Our Genes Influence How Sensitive We Are
JUN 10, 2020
Our Genes Influence How Sensitive We Are
Maybe you've been told that you are too sensitive, or you know someone who has strong reactions to positive, negative, o ...
JUN 01, 2020
Neuroscience
New Path to Gene Therapy for ALS
JUN 01, 2020
New Path to Gene Therapy for ALS
Video: Todd Cohen, PhD (UNC) discusses GA protein accumulation.  At the time of this video promising research was a ...
JUL 13, 2020
Genetics & Genomics
New Therapeutic Targets For Lupus Are Identified
JUL 13, 2020
New Therapeutic Targets For Lupus Are Identified
Advances in computational and genetic technologies have enabled scientists to search the genome to look for places where ...
AUG 11, 2020
Neuroscience
Personality Traits Inherited Within 2 Generations
AUG 11, 2020
Personality Traits Inherited Within 2 Generations
By selectively breeding zebrafish, researchers from the Max Planck Institute have found that distinct personality traits ...
Loading Comments...